EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expression Levels of MUC5AC and MUC5B in Airway Goblet Cells Are Associated with Traits of COPD and Progression of Chronic Airflow Limitation

Terezia Pincikova, Heta Merikallio iD, Ioanna Kotortsi, Reza Karimi, Chuan-Xing Li, Elisa Lappi-Blanco, Sara K Lindén iD, Médea Padra, Åsa M Wheelock, Sven Nyrén, Carl Magnus Sköld, Riitta L Kaarteenaho

International Journal of Molecular Sciences · 20.12.2024 · 25 (24) · 13653

DOI: 10.3390/ijms252413653 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.12.2024. Verfasst von Terezia Pincikova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Medicine Unit, Department of Medicine Solna and Center for Molecular Medicine, Karolinska Institute, 171 76 Stockholm, Sweden. Hauptthemen laut MEDLINE: Mucin 5AC, Mucin-5B, Pulmonary Disease, Chronic Obstructive, Goblet Cells. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Foundation of the Finnish Anti-Tuberculosis Association, The Jalmari and Rauha Ahokas Foundation, The Research Foundation of the Pulmonary Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucins 5AC (MUC5AC) and 5B (MUC5B) are the major mucins providing the organizing framework for the airway’s mucus gel. We retrieved bronchial mucosal biopsies and bronchial wash (BW) samples through bronchoscopy from patients with chronic obstructive pulmonary disease (n = 38), healthy never-smokers (n = 40), and smokers with normal lung function (n = 40). The expression of MUC5AC and MUC5B was assessed immunohistochemically. The mucin concentrations in BW were determined using the slot-blot technique. The immunohistochemical expression of MUC5AC and MUC5B was localized to goblet cells and submucosal glands. Smokers had higher MUC5AC and lower MUC5B goblet cell expression and higher concentrations of soluble MUC5AC in BW than never-smokers. The MUC5B expression in goblet cells correlated positively with expiratory air flows, diffusing capacity, and the dyspnoea score. Chronic bronchitis, emphysema, and the progression of chronic airflow limitation during a median follow-up time of 8.4 years were associated with higher MUC5AC and lower MUC5B expression in goblet cells. Sustainers, slow progressors, and rapid progressors of airflow obstruction differed in their MUC5B expression at baseline. Emphysema and bronchial wall thickening on CT at a follow-up visit were associated with lower MUC5B expression at baseline. Our findings strengthen the hypothesis that MUC5AC and MUC5B are yet another contributing factor to smoking-associated lung disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mucin 5ACMucin-5BPulmonary Disease, Chronic ObstructiveGoblet CellsDisease ProgressionHumansMaleFemaleMiddle AgedAgedSmoking

Stichwörter der Autor:innen

COPDepitheliumimmunohistochemistrymucinsmoking

Substanzen

Mucin 5ACMucin-5BMUC5B protein, humanMUC5AC protein, human

Autor:innen und Institutionen

  • Respiratory Medicine Unit, Department of Medicine Solna and Center for Molecular Medicine, Karolinska Institute, 171 76 Stockholm, Sweden.
  • Stockholm CF-Center, Albatross, K56, Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden.
  • Research Unit of Biomedicine and Internal Medicine, University of Oulu, 902 20 Oulu, Finland.
  • Center of Internal Medicine and Respiratory Medicine, Medical Research Center Oulu, Oulu University Hospital, 902 20 Oulu, Finland.
  • Department of Respiratory Medicine and Allergy, Karolinska University Hospital, 171 76 Stockholm, Sweden.
  • Cancer and Translational Medicine Research Unit, Department of Pathology, Oulu University Hospital and University of Oulu, 902 20 Oulu, Finland.

ORCID-Profile: Heta Merikallio, Sara K Lindén

Förderung

  • The Foundation of the Finnish Anti-Tuberculosis Association
  • The Jalmari and Rauha Ahokas Foundation
  • The Research Foundation of the Pulmonary Diseases
  • A state subsidy of Oulu University Hospital
  • The Swedish Heart-Lung Foundation
  • The Swedish Respiratory Society
  • King Gustaf V's and Queen Victoria's Freemasons' Foundation
  • Hesselmans Foundation

Zitieren

APA

Pincikova, T., Merikallio, H., Kotortsi, I., Karimi, R., Li, C. X., Lappi-Blanco, E., Lindén, S. K., Padra, M., Wheelock, Å. M., Nyrén, S., Sköld, C. M., & Kaarteenaho, R. L. (2024). Expression Levels of MUC5AC and MUC5B in Airway Goblet Cells Are Associated with Traits of COPD and Progression of Chronic Airflow Limitation. International Journal of Molecular Sciences, 25(24), 13653. https://doi.org/10.3390/ijms252413653

Vancouver

Pincikova T, Merikallio H, Kotortsi I, Karimi R, Li CX, Lappi-Blanco E, et al. Expression Levels of MUC5AC and MUC5B in Airway Goblet Cells Are Associated with Traits of COPD and Progression of Chronic Airflow Limitation. International Journal of Molecular Sciences. 2024;25(24):13653. doi:10.3390/ijms252413653

BibTeX
@article{Pincikova2024,
  author = {Pincikova, Terezia and Merikallio, Heta and Kotortsi, Ioanna and Karimi, Reza and Li, Chuan-Xing and Lappi-Blanco, Elisa and Lindén, Sara K and Padra, Médea and Wheelock, Åsa M and Nyrén, Sven and Sköld, Carl Magnus and Kaarteenaho, Riitta L},
  title = {Expression Levels of MUC5AC and MUC5B in Airway Goblet Cells Are Associated with Traits of COPD and Progression of Chronic Airflow Limitation},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {24},
  pages = {13653},
  doi = {10.3390/ijms252413653}
}
Kostenlos starten →